Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema

Acta Ophthalmologica

Volumn 88, Issue 2, 2010, Pages

  Kumar, Vinod ^a   Ghosh, Basudeb ^a   Raina, Usha K ^a   Goel, Neha ^a  

^a Guru Nanak Eye Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

DIABETIC MACULAR EDEMA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULOPATHY; SEROUS MACULAR DETACHMENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; HUMANS; INJECTIONS; MACULAR EDEMA; RETINAL DETACHMENT; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 77649197884     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01575.x     Document Type: Letter

References (4)

1. Fang X, Sakaguchi H, Gomi F et al. (2008 Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema. Acta Ophthalmol 86 : 800 805.
2. Gaucher D, Sebah C, Erginay A et al. (2008 Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol 145 : 289 296.
3. Otani T, Kishi S Maruyama Y (1999 Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 27 : 688 693. (Pubitemid 29266745)
4. Ozdemir H, Karacorlu M Karacorlu SA (2005 Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. Am J Ophthalmol 140 : 251 255.